Welcome from the Division Chiefs
Welcome to the website for the Division of Infectious Diseases & HIV Medicine at Case Western Reserve University. We are incredibly proud of our tradition and accomplishments in contributing to the advancement of treatment of infectious diseases locally, nationally and worldwide.
Our core mission is to heal, to teach and to discover. Facing the challenges of emerging and re-emerging infectious diseases at home and across the globe; we pride ourselves on delivering the highest quality of care for our patients, providing exceptional fellowship training to the next generation of Infectious Diseases physicians and continuing to make scientific breakthroughs through our world renowned research.
Can a novel combination of treatments help eradicate HIV?
In first-ever study, School of Medicine researchers to pair monoclonal antibody with body’s own killer-cell stimulator
A Case Western Reserve University School of Medicine researcher received a $2.5 million grant from Gilead Sciences, a California-based biopharmaceutical company, to see if two so-far separately used AIDS treatments are even more effective when used as a pair.
Lead researcher Michael M. Lederman, the Scott R. Inkley Professor of Medicine, and colleagues will combine interleukin-2, a protein made by the body that stimulates human killer-cells, with a lab-engineered monoclonal antibody that targets HIV.
CWRU receives grant to study why some HIV positive people resist TB
Crain's Business Cleveland
Case Western Reserve University School of Medicine experts and colleagues in the United States and Africa have received an $11 million federal grant to study how some people living with the human immunodeficiency virus (HIV) in Africa avoid contracting tuberculosis.
The five-year grant will support work to learn what causes resistance to the bacterium that causes TB. Understanding this could have a significant global health impact, as TB is the leading cause of death worldwide among people living with HIV, with one in three HIV deaths estimated to be due to TB, according to a news release.
Faculty Distinguished Research Award Winner
In his 36 years as a faculty member, Dr. Lederman has made an incredible impact on Case Western Reserve University School of Medicine. But his contributions extend well beyond campus.
Two years after the discovery of HIV/AIDS in 1981, Lederman began researching the disease, focusing mainly on understanding and addressing HIV-induced immune deficiency. Then, two years into his work, he established the first dedicated HIV clinic in Northeast Ohio.
Lederman is responsible for the AIDS Clinical Trials Unit at Case Western Reserve and directs the network of Immunology Service Laboratories, which monitors national HIV treatment trials. His leadership extends into his involvement in the Association of American Physicians, the American Association of Immunologists, the Infectious Diseases Society of America, the HIV Medicine Association, the American Association of Microbiology and the American Association for the Advancement of Science. Read more...